EB
Emily Bodnar
#298 out of 1697 analysts
HC Wainwright & Co.
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
35.54%
Gain +4.38%
Monthly
-0.56%
Yearly
-6.58%
Drawdown
60.87%
$103,630.11
Equity
Holdings
$62,579.9
Cash
$41,050.21
Investment
$61,575.31
-$37,420.62
Profit +$4,354.08
Realized
-$38,425.21
Unrealized
$1,004.59
Dividends
$0
$41,050.21
Cash
Deposits
$141,050.73
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
4.38%
Profit
$4,354.08
Win %
33%
This Week
Compared To Last Week
Gain
1.33%
Profit
$1,360.98
Win %
66%
This Month
Compared to last month
Gain
8.32%
Profit
$7,962.82
Win %
69%
This Year
Compared to last year
Gain
20.7%
Profit
$17,770.78
Win %
55%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 2063 | Longs Won 907/2062 43% | Profit Factor 0.78 |
| Profitability | Shorts Won 0/1 0% | Standard Deviation $674.86 |
| Average Win $142.87 | Best Trade (Nov 01) $4,934.41 | Sharpe Ratio -802.62 |
| Average Loss -$144.46 | Worst Trade (May 13) -$19,148.94 | Z-Score -13.41 (100%) |
| Commissions $0 | Avg. Trade Length 2m 2w 4d | Expectancy -$18.14 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 717 | 646 | 574 | 502 | 430 | 359 | 287 | 215 | 143 | 72 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
 COAG Hemab Therapeutics Holdings, Inc. | 396.7 | $20,525.1 | $21,794.53 | - | $1,269.43 | 6.18% | +1.835% |
 NKTX Nkarta Inc. | 8,809.06 | $20,525.1 | $20,525.1 | - | - | - | +1.304% |
 PPBT Purple Biotech Ltd. | 13,242 | $20,525.1 | $20,260.26 | - | -$264.84 | -1.29% | +2.341% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
